Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

The NSW government has announced an investment of A$20.7m ($13.39m) aimed at providing access to life-changing therapies.

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine ...

Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule ...

AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications ...

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its ...

BioOrbit CEO Dr Katie King said that pre-clinical studies of the crystals produced in space could start as early as 2026.

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.